GPR109A (PUMA-G/HM74A) mediates nicotinic acid–induced flushing

Nicotinic acid (niacin) has long been used as an antidyslipidemic drug. Its special profile of actions, especially the rise in HDL-cholesterol levels induced by nicotinic acid, is unique among the currently available pharmacological tools to treat lipid disorders. Recently, a G-protein–coupled recep...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Benyó, Zoltán, Gille, Andreas, Kero, Jukka, Csiky, Marion, Suchánková, Marie Catherine, Nüsing, Rolf M., Moers, Alexandra, Pfeffer, Klaus, Offermanns, Stefan
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Clinical Investigation 2005
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1297235/
https://ncbi.nlm.nih.gov/pubmed/16322797
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI23626
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados